Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers

Study Overview
=================
Brief Summary
-----------------
This study evaluates the role of socioeconomic and individual factors in the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) in oeso-gastric cancer.

Detailed Description
-----------------
Reducing the time between the onset of the first symptoms of cancer and the first consultation with a doctor (patient delay) is essential to improve the vital prognosis and quality of life of patients. Recent data suggest that some sociocognitive and emotional determinants may explain patient delay from a complementary point of view. The main objective of this study is to assess whether, in oeso-gastric cancer, patient delay is linked to these sociocognitive and emotional factors, in addition to previously known factors. We intend to include in this study 300 patients with a not yet treated oeso-gastric cancer diagnosed in one of 10 health centres in the North of France region. The collected data will be analysed to underline the differences between patients who consulted a doctor earlier versus those who consulted later with a cut off at 8 weeks.

Official Title
-----------------
Individual and Socio-economic Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers

Conditions
-----------------
Oesophageal Carcinoma, Gastric Adenocarcinoma

Intervention / Treatment
-----------------
* Other: Questionnaire


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: age ≥ 18 years oesophageal, oeso-gastric junction or gastric cancer non treated cancer patient informed of his diagnosis speak fluent french Exclusion Criteria: history of cancer psychological history patient under guardianship- fortuitous diagnosis of cancer

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Prevention
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Questionnaire<br>Auto and hetero questionnaire | Other: Questionnaire<br>* Auto and hetero questionnaires: STAI Y B, State-Trait Anxiety Inventoriage Brief COPE RHHI-24, Revised Health Hardiness Inventory IPQ-R, Illness Perception Questionnaire<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Time limit of first doctor consultation | Median time between date of symptoms appearance and date of first consultation | baseline | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Time limit of system of care | Median time between date of he beginning of clinical investigations and the beginning of treatment | baseline | 
| cTNM Stage | Stage TNM by distinguishing the early stages (I, II) vs. (III, IV) | baseline | 
| clinical variables (i.e medical history, symptoms, entry into care pathway) | clinical variables associated with time of first doctor consultation | baseline | 
| Socio-cognitive variables | Socio-cognitive variables associated with time of first doctor consultation | baseline | 
| Emotional variables | Emotional variables associated with time of first doctor consultation | baseline | 
| Survival |  | At 3 years |